Vantage Galan 3T, MRT-3020, V10.0 with AiCE Reconstruction Processing Unit for MR

The Vantage Galan 3T, MRT-3020, V10.0 with AiCE Reconstruction Processing Unit is a magnetic resonance diagnostic system designed to produce high-quality cross-sectional images by exploiting nuclear magnetic resonance properties of body tissues. Recent modifications, including an expanded Precise IQ Engine and minor software updates, have been validated through rigorous testing to enhance image sharpness and reduce artifacts, thereby maintaining its safety and effectiveness for diagnostic imaging.

The Vantage Galan 3T, MRT-3020, V10.0 with AiCE Reconstruction Processing Unit for MR, a magnetic resonance diagnostic device from Canon Medical Systems Corporation, is designed to generate cross-sectional images of the head or body, including non-contrast enhanced MRA, by leveraging the nuclear magnetic resonance properties of body tissues and fluids. This diagnostic imaging system has been determined to be substantially equivalent to an already available device for its intended diagnostic indications, confirming its core purpose and scientific principle. The latest submission details key modifications to the system, encompassing the addition of a standard gradient system, an expansion of the Precise IQ Engine (PIQE) to cover more scan families and anatomical areas, and minor software updates. Comprehensive evaluations, including bench tests, image quality assessments, and a multi-site clinical image review study for PIQE, collectively demonstrated that these enhancements lead to improved image sharpness, reduced artifacts, and maintained or superior overall image quality, affirming the device's continued safety and effectiveness for diagnostic imaging without altering its intended use.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific clinical benefits does the expanded PIQE offer across different anatomical areas compared to previous versions?; How does the AiCE Reconstruction Processing Unit integrate with the Precise IQ Engine (PIQE) to achieve the reported image quality improvements?; Are there any specific patient populations or types of pathologies for which the Vantage Galan 3T with these modifications shows a significant diagnostic advantage?; What were the quantitative metrics used in the image quality evaluations and multi-site clinical review study to objectively assess sharpness and artifact reduction?; What are the long-term implications or potential future developments expected from the integration of standard gradient systems and advanced reconstruction technologies in MR imaging?